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Abstract
Background: Investigation of preschool asthma is important since not all children 
outgrow their illness during this age. Data are scarce on the role of rhinovirus (RV) 
infections in this patient group.
Objectives: To investigate the role of RV infections in preschool asthma: (i) suscepti-
bility factors, (ii) clinical course, and (iii) medium-term outcome.
Methods: A total of 130 asthmatic children aged 4-6 years from the multinational 
PreDicta cohort were prospectively followed for a 12-month period. Allergy tests 
and a standard health questionnaire were carried out at study entry. Respiratory 
virus presence in nasopharyngeal washes was studied at illness visits and at 3 sched-
uled visits.
Results: At study entry, mean age of the children was 5.3 years. Of 571 visits, 54% 
were positive for any virus and 39% for RV. Patient characteristics were only as-
sessed with RV infection due to low number of other viruses. The use of supplemen-
tary vitamin D was inversely associated with RV infection (P < .05). RV infection was 
associated with more severe course of acute illness in terms of more severe nighttime 
coughing, more sleep disturbances, and more days with runny nose (all P < .05). RV 
infection was also associated with more severe disease course during the 12-month 
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1  | INTRODUC TION
Asthma is the most common chronic disease among children in 
industrialized countries. In Europe, the prevalence of childhood 
asthma has increased during last decades; in 2017, the prevalence 
at the age of 4 years varied from 2% to 13% depending on country.1 
Thus, asthma creates a major burden on public health, with the mean 
cost per patient per year estimated to be 1700 € in Europe consid-
ering all asthmatics.2
Respiratory viral infections are the almost exclusive trigger of 
wheezing episodes in early life, a condition affecting approximately 
30% of children.3 Rhinovirus (RV) is the most commonly identified 
culprit, and interestingly, RV-induced wheezing has been shown to 
be a strong predictor of recurrent wheezing and a major risk fac-
tor for school-age asthma (odds ratios up to 20-45 depending on 
concomitant asthma risk allele and/or aeroallergy).4-6 Other main 
risk factors of asthma include atopic dermatitis, family history of 
asthma, aeroallergen sensitization, exposure to smoke, and male 
gender.7 Among children with asthma, RV infections are also the 
main trigger of acute exacerbations.7,8 However, data are scarce on 
the role of RV infections in preschool age children with asthma.9,10 
The investigation of preschool asthma is important since many 
children outgrow their illness during this age while in others the 
disease persists.
RV is a potentially valuable clinical marker of asthma persistence/
morbidity in preschool age children with recurrent wheezing/
asthma. Therefore, our goal was to examine factors associated with 
susceptibility to virus infections as well as clinical aspects of such 
infections in asthmatic preschoolers, with a special focus on RV. We 
had three specific aims: first, to identify characteristics of children 
with preschool asthma associated with (susceptibility to) symptom-
atic or asymptomatic RV infections; second, to assess whether RV 
follow-up in terms of more nights with awakenings and more days of exercise-related 
symptoms (both P < .05).
Conclusions: Vitamin D supplementation may have an anti-rhinovirus effect. Both 
short- and medium-term outcomes suggest RV infection to be an important clinical 
marker of instable preschool asthma.
K E Y W O R D S
asthma, child, preschool, rhinovirus, vitamin D
G R A P H I C A L  A B S T R A C T
This study investigated the role of rhinovirus (RV) infections in preschool asthma in 130 asthmatic children from PreDicta cohort over 1-year 
follow-up. During all visits, RV was the most commonly detected virus. Vitamin D supplementation was associated with decreased number 
of rhinovirus infections in preschool children with asthma. Detection of RV was associated with more severe course of acute illness (more 
severe nighttime coughing, more sleep disturbances, and more days with runny nose) and more compromised medium-term prognosis (more 
nights with awakenings and more days of exercise-related symptoms).
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infections are associated with more severe clinical course of acute 
respiratory illness in comparison to other viruses or where no virus 
was identified, and third, to evaluate whether susceptibility to RV 
infections is associated with a more compromised 12-month asthma 
course. We hypothesized that there are likely to be factors that in-
crease susceptibility for RV infections and, further, that RV infec-
tions may be associated with more severe short- and medium-term 
clinical course of preschool asthma.
2  | METHODS
2.1 | Subjects
This study was part of the PreDicta cohort (postinfectious immune 
reprogramming and its association with persistence and chronicity 
of respiratory allergic diseases). Recruitment was carried out in five 
study centers in Europe: in Athens, Greece, Turku, Finland, Lodz, 
Poland, Ghent, Belgium, Erlangen, and Germany. Characteristics of 
the subjects, inclusion and exclusion criteria, and study design have 
been described in detail before.11 In brief, main inclusion criteria 
consisted of a written informed consent from the child's parents/
guardians, age 4-6 years, gestational age of 36 weeks or above and 
a doctor-diagnosed asthma within the last 2 years, mild to moderate 
persistence's severity according to GINA.12 Main exclusion criteria 
were severe or brittle asthma, children receiving immunotherapy, 
other chronic nonatopic disease. The study was commenced only 
after obtaining written informed consent from the parents or a 
guardian. The study protocol was approved by the Ethics Committee 
of all participating hospitals.
2.2 | Study protocol
At study entry, a guardian filled out a standardized questionnaire 
on symptoms of asthma, rhinitis, eczema, infections, immunizations, 
environmental factors, and family history in the preceding 12-month 
period. In order to be included at baseline, children had to be asymp-
tomatic for at least 4-6 weeks. Baseline blood tests and nasopharyn-
geal swab samples were obtained (see below). Follow-up visits were 
arranged at 6-month intervals for 2 years, where guardians were 
asked to fill out a questionnaire on symptoms of asthma/rhinitis ac-
tivity (Figure S1). Respiratory symptoms and medications were also 
recorded in a daily symptom diary.
In addition to the scheduled visits, guardians were instructed 
to contact the study center if the child developed signs of a respi-
ratory tract infection, exacerbation of asthma, a symptom score 
according to the diary cards of 4 or over, or a decrease in forced 
expiratory volume in one second >15% or in peak expiratory flow 
>30%. An additional visit to the clinic was then arranged, for patho-
gen identification.
At each visit, nasopharyngeal sample was collected with the use 
of a nasal applicator swab, which has a tip with flocked soft nylon 
fiber (ESwab 482CE; Copan Italia). Immediately after collection, the 
specimen was transported to the laboratory and stored at −80°C for 
later analysis.
2.3 | Definitions
Childhood asthma refers to repeated attacks of airway obstruction 
and intermittent symptoms of increased airway responsiveness to 
triggering factors, such as exercise, allergen exposure, and viral in-
fection.12,13 “Wheezing” refers to expiratory breathing difficulty as 
a result of airway obstruction with a high-pitched bilateral sound 
during expiration. The presence of allergic sensitization was de-
fined by having one or more positive values for allergen-specific IgE 
(>0.35 kU/L, Phadiatop Combi; Phadia, Uppsala, Sweden). Skin prick 
tests were performed optionally for additional atopy determination 
using 7 common allergens: normal saline, histamine (10 mg/mL), 
dermatophagoides mix, cockroach, cat, alternaria, and grass mix in 
all centers. In addition, birch and Ambrosia were used in Ghent, Lodz, 
Erlangen and Turku and Parietaria and olive in Athens. Virus infection 
refers to a positive virus detection using PCR, irrespective of respira-
tory symptoms.
2.4 | Outcomes
Aim 1: The first study question investigated whether certain host 
characteristics at baseline were associated with the presence of RV 
vs. non-RV. RV infection was defined as a positive RT-PCR test of 
nasopharyngeal swab sample whether symptomatic or not during 
the 24-month follow-up period. RV group may include other viruses. 
Non-RV group includes other virus and virus-negative findings.
Aim 2: The second study question investigated whether the de-
tection of RV vs. non-RV in an acute respiratory illness was asso-
ciated with more severe disease course. The symptom data were 
based on the diary records.
Aim 3: The third study question investigated whether suscepti-
bility RV vs. non-RV infection as defined in aim 1 was associated with 
more severe medium-term (12-month) prognosis, based on all clinical 
visits and diary records.
2.5 | Laboratory methods
Virus transport mediums (ESwab 482CE; Copan Diagnostics, 
Murrieta, CA, USA) were transported from study centers on dry ice 
and analyzed for respiratory viruses at the Department of Virology, 
University of Turku. Entero-, rhino- (species A, B, and C), and res-
piratory syncytial viruses were detected using an in-house RT-PCR 
test.14 The first one hundred Finnish samples were also tested for 
adenovirus, human metapneumovirus, coronavirus 229E/NL63, 
parainfluenza viruses 1, 2, or 3, influenza viruses A or B, respiratory 
syncytial virus A or B, rhinovirus A/B, and coronavirus OC43/HKU1 
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by a commercial multiplex PCR test (Seeplex RV12 ACE Detection 
kit). Thereafter, the test was replaced by a new test version of the 
same manufacturer and all remaining samples were assessed by 
Anyplex RV16 Detection kit (Seegene, Soul), which identifies adeno-
virus, influenza A and B, parainfluenza viruses types 1-4, rhinovirus 
A, B, and C, respiratory syncytial virus A and B, human bocavirus 
1-4, metapneumovirus, coronavirus 229E, NL63 and OC43, and 
enterovirus.
2.6 | Statistics
The association between categorical baseline characteristics and 
susceptibility to rhinovirus infections was analyzed using chi-
squared test or Fisher's exact test and continuous baseline charac-
teristics using Mann-Whitney U test. Analyses were extended to 
group baseline characteristics as number of sensitizations, allergic 
diseases ever (atopic eczema, allergic rhinitis diagnosis, adverse 
reaction to food, bee, wasp or latex, and/or skin prick test positive 
for aeroallergens at study entry); parental allergic illnesses ever 
(eczema, allergic rhinitis, asthma and/or adverse reaction to food); 
moderate-to-severe asthma (asthma severity at least moderate 
persistent, asthma treatment during last 3 months, peak expira-
tory flow <80%), exposure to any air impurity factor (animal ex-
posure on a weekly basis, parental smoking, trucks through street 
at least frequently though the day, mold spots, and/or window 
condensation at home), and exposures to animal and other air im-
purity factors separately. The associations between RV infection 
and symptoms of asthma were examined with Mann-Whitney U 
test. The associations between continuous parameters describ-
ing activity of asthma and RV were analyzed using Mann-Whitney 
U test, because the continuous variables were not normally dis-
tributed. A two-sided P < .05 was considered statistically signifi-
cant, and no adjustment was made for multiplicity. We used SAS/
STAT(r) version 9.4 of the SAS System for Windows (SAS Institute 
Inc, Cary, NC, USA).
3  | RESULTS
3.1 | Study cohort
The enrollment of the study subjects and data sets for each study 
aim are shown in Figure 1. Originally, 167 children were recruited 
into the case group (diagnosed asthma) and 75 children into the 
control group in 5 study centers. Over 1-year period, one patient 
dropped out after the baseline visit, 70 patients were not sampled 
for viruses from follow-up visits, while 41 patients had data from 
only 1 follow-up visit. A total of 131 patients, one of which in control 
group, had virus data from at least 2 follow-up visits. Finally, we have 
analyzed 130 patients for whom virus data from at least 2 follow-up 
visits were available (Turku = 42, Lodz n = 39, Athens n = 26, Ghent 
n = 12, Erlangen n = 11).
3.2 | Patient characteristics
Baseline characteristics of 130 study children who had virus data 
available from at least two scheduled visits are shown in Table 1, 
and Table S1. At study entry, 62% of them were boys, 55% had 
aeroallergen sensitization, 38% had active atopic eczema, and 
38% had vitamin D supplementation. The severity of asthma was 
mainly mild persistent (59%) or intermittent (25%), and 83% of 
subjects had peak expiratory flow in normal range. Inhaled cor-
ticosteroid was the most common asthma control medication 
(83%), 34% of parents smoked and 42% had indoor pets. Of all 
571 visits (scheduled and illness visits), viruses were detected 
in 307 (54%). RV was the most common finding (39%), whereas 
each other virus was found in <5% of visits. RV was detected 
significantly more often at illness compared to scheduled visits 
(58% vs 34%, P < .0001). Virus coinfections were found in 6.7% 
(38/571) of all visits (Table S2). No difference in their prevalence 
was found between RV-positive (16/222, 7.2%) vs. RV-negative 
groups (22/349, 6.3%) (P = .67).
F I G U R E  1   Study flowchart242 children enrolled for PreDicta
All 167 children with asthma
completed 1-year follow-up
57 patients had data from
one and 20 patients from
two illness visits from a 2 
year period
Aim 1: susceptibility 
factors for RV infection
130 patients had data 
from at least 2 follow-up
visits from a 2 year
period, a total of 571 visits
Aim 3: medium-term 
outcome of RV infection
115 patients had data from >2 
scheduled or 1 scheduled and 
1 illness visit from a 1-year 
period, a total of 321 visits
75 controls without 
history of wheeze, 
asthma or atopic 
disease were
excluded, since only
one had data from at 
least 2 visits
Aim 2: clinical
course of RV infection
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3.3 | Susceptibility to rhinovirus infections
Patient characteristics at baseline were only compared with RV 
(n = 109) vs. non-RV (n = 21) infection due to low number of 
other virus findings. The use of vitamin D supplementation was 
inversely associated with RV infection at any visit (scheduled and 
illness visits) (proportion of children with supplementation, RV+ vs 
RV- group, 76% vs 89%, P = .049, Table S3). The association per-
sisted after adjusting to study center, P = .0496). Use of vitamin 
D-fortified food items (milk, cereal, or yoghurt) was not associated 
with RV detection (P > .1, Table S2). We further analyzed the as-
sociation between vitamin D supplementation at study entry and 
symptomatic rhinovirus illnesses but no association was found: 
positive RV findings in children without vit-D vs with vit-D, 69.6% 
(32/46) vs 70.0% (14/20), P > .9. No other associations were found 
(Table S3) even if baseline characteristics were grouped as num-
ber of sensitizations, atopic disease ever, parental allergic illnesses 
ever moderate-to-severe asthma, or any pollutant exposure (all 
P > .1, data not shown).
3.4 | Clinical characteristics of virus infections
Clinical characteristics of acute events were studied by investigat-
ing the connection between the virus findings during the course of 
an acute respiratory illness and symptom severity. Of 130 asthmatic 
children, 57 children had virus information available from illness visit 
1 and 20 children from illness visit 2 (Table S4). RV infection was as-
sociated with increased cough during the night (P = .029) and sleep 
disturbances (P = .015), but less ophthalmic symptoms (P = .041) at 
illness visit 1 and with increased runny nose (P = .008) at illness visit 
2 (Figure 2, Online Table E3).
3.5 | Virus findings and asthma activity
The connection between RV infections at any time-point (sched-
uled or illness visits) and asthma activity was analyzed within 
1-year follow-up (Table S5). It was found that RV infection was as-
sociated with increased activity of asthma in terms of more nights 
with awakenings (P = .026) and more days with exercise-related 
symptoms (P = .041, Figure 3). Moreover, RV infection at base-
line was associated with increased days of rhinitis within the 12-
month follow-up (50% vs 25% had rhinitis >4 days per week within 
6 months, P = .024).
4  | DISCUSSION
This study had three important findings in children with preschool 
asthma: First, of many personal (age, sex, atopic characteristics, 
TA B L E  1   Baseline characteristics
Characteristics N = 130
Age, mean (SD) 5.3 (0.7%)
Male 80 (62%)
Allergic diseases ever
Atopic eczema 74 (57%)
Symptoms within past 12 months 50 (38%)
Allergic rhinitis diagnosis 91 (70%)
Symptoms within past 12 months 109 (84%)
Adverse reaction to food 48 (37%)
Adverse reaction to bee or wasp 20 (15%)
Adverse reaction to latex 1 (1%)
Asthma severity
Intermittent 32 (25%)
Mild persistent 77 (59%)
Moderate persistent 21 (16%)
Severe persistent 0 (0%)
Asthma treatment during last 3 months
Inhaled corticosteroid 108 (83%)
Leukotriene receptor antagonist 55 (42%)
Long-acting beta2-agonist 20 (51%)
Status at study entry





Parental smoking 44 (34%)
Parental allergic illnesses ever
Eczema 47 (36%)
Allergic rhinitis 81 (62%)
Asthma 51 (39%)
Adverse reaction to food 34 (26%)
Animal exposure on a weekly basis
Indoor pets 54 (42%)
Cat 24/77 (31%)
Dog 30/76 (39%)
Farm animal 4/76 (5%)
Other 17/76 (22%)
Breastfed 110 (85%)
Vitamin D supplementation 45/119 (38%)
In milk 62/112 (55%)
In cereal 40/103 (39%)
In yogurt 48/112 (43%)
Note: Data are shown as number of patients (%) unless otherwise 
expressed.
See more patient characteristics in Table S1.
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asthma severity, physical activity, breast feeding, and vitamin D sup-
plementation), family (atopic characteristics and education level), 
and environmental (pet ownership, farm animal exposure, and air 
pollutants) factors, only vitamin D supplementation was associated 
with decreased susceptibility to RV infections. Interestingly, atopic 
sensitization was not. Second, RV triggered acute respiratory illness 
was associated with more severe course of the illness; and third, 
susceptibility to RV infection was associated with increased asthma 
activity during the following 12-month period.
Our findings of potential protective role of vitamin D against re-
spiratory infections are supported by many clinical studies in children 
and in vitro studies,15-18 although contradictory reports also exist in 
adults.19,20 Low levels of vitamin D or lack of supplementation have 
been associated with increased risk of respiratory infections as well 
as coinfections in children.15,16 Specific association to RV infections, 
however, has received less attention, and results have been incon-
clusive.21,22 High vitamin D levels may have partly explained the lack 
of meaningful correlations in some cases.21 Our findings support the 
protective role of vitamin D against RV infections which is particu-
larly important in asthmatic children since RV is the major trigger of 
exacerbations23 and vitamin D levels were inversely related to mea-
sures of asthma severity.24 Collectively, available data strongly sup-
port antiviral effects of vitamin D3 supplementation (recommended 
7.5-25 µg/day in many European countries but not necessarily during 
summer times) and its usage in young asthmatic patients. In addition, 
many food items are fortified with vitamin D. Our data support the 
view that vitamin D supplementation, and not vitamin D fortified 
food items, is the best source.
Asthma-prone children appear to be more susceptible to RV in-
fections than healthy children.7 Our findings in preschool children 
support these findings by showing that RV detection during acute 
illness was positively associated with measures of illness severity. 
However, the exact mechanisms are not precisely known but most 
plausible explanation is that asthmatic children have weaker antiviral 
defense than healthy children. This is likely to be due to predispo-
sition (genetically low interferon α/β/γ/λ levels and low interleukin 
[IL]-10 levels thereby weakened antiviral defense and anti-inflamma-
tory control), T helper2 type risk factors of asthma (allergen expo-
sure and high-affinity IgE receptor cross-linking have been shown to 
impair type I and III interferon production and increased production 
of T helper2 cytokines IL-4, IL-5, and IL-13 in airway secretions coun-
teract T helper1 responses), and interactions between the under-
lying inflammatory pathways (RV infections and allergens enhance, 
for example, the airway epithelial cell production of IL-25 and IL-33, 
which promote T helper2 airway inflammation; T helper2 polarized 
immune responses may increase the expression of ICAM-1, and dis-
rupted airway epithelium favors RV replication).7 Delayed matura-
tion of antiviral responses may also contribute at this age range.25 
Thus, genetically weak antiviral mechanisms may be further atten-
uated by airway inflammation and, in our case, also by low vitamin 
D status. Moreover, antiviral mechanisms are likely to be, at least 
partly, RV-specific since genetic variants at the 17q21 locus and in 
CDHR3 allele may markedly increase the risk of severe RV infections 
although not investigated in our study.5,6
Negative findings in many investigated personal, family, and en-
vironmental factors further support the compromised virus defense 
as the key element in the susceptibility to RV infections. More se-
vere RV infections are known to be closely associated with atopic 
asthma,4,26 but surprisingly atopic characteristics (investigated sep-
arately and as a group) were not associated with susceptibility to 
RV infection even though a half of our children were sensitized to 
aeroallergens. Also, air pollutants, especially exposure to allergens, 
but also traffic pollutants such as NO2, increase risk of virus-induced 
exacerbation of asthma.27,28 However, we did not find association 
between exposure to these pollutants (separately or as a group) and 
susceptibility to RV infections. The probable explanation for these 
F I G U R E  2   The association between 
rhinovirus detection and respiratory 
symptoms at illness visits. Significant 
and positive associations were found 
with (A) nighttime coughing, (B) sleep 
disturbances, (C) runny nose, and 
a tendency with (D) the severity of 
exacerbation. Data are shown as mean 
(standard error of mean) for better 
visualization and are analyzed using 
Mann-Whitney U test
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null findings is that our children were using regular asthma controller 
medication. Parental smoking does not appear to have strong influ-
ence on the susceptibility to RV infections.26,29 As expected, breast 
feeding during infancy was not associated with virus susceptibility 
at preschool age.
Our findings also indicate that susceptibility to RV infections, 
whether symptomatic or asymptomatic, serves as an important clin-
ical marker for more compromised prognosis of asthma. It is known 
previously that RV-induced wheezing is an important risk factor for 
subsequent wheezing and later asthma among young wheezing chil-
dren.7 Already at the time of first severe wheezing episode, its pres-
ence can predict school-age atopic asthma (odds ratio 5.0 in normal 
population).26 This risk value of RV detection in wheezing children 
has been extended to the first three years of life.4 It has been specu-
lated that this risk may be limited to early wheezing only. Our results 
contrast these speculations and extend the prognostic value of RV 
infection in preschool to school-age asthma. RV detection among 
wheezing children appears to be particularly important since it also 
effectively predicts steroid-responders.30,31 It should be noted that 
increased RV expression in asthmatics may suppress secondary 
virus infections, thus further promoting the role of RV in asthmatic 
subjects.32
The PreDicta cohort has many strengths including careful char-
acterization of study subjects, serial virus detection as well as pro-
spective, multi-center, and multinational design. In-house RT-PCR 
effectively covered all RV species.33 There are also weaknesses. 
Sample size only allowed RV-specific analyses since the number of 
other virus detections was low. However, RV was our main focus. 
A longer than 12-month follow-up time may have revealed more 
risk factors. Days with exercise symptoms were determined sub-
jectively by parents. Also, sample size for some risk factors was 
likely to be low, but analyses were repeated by uniting them into 
larger groups, for example, by uniting any atopic characteristics 
under one variable. Correction for multiple comparisons was not 
done due to explorative nature of the analysis. Due to large study 
setting and multidisciplinary approach, several predefined sub-
analyses to assess causality and interrelations have not yet been 
completed.
In conclusion, vitamin D supplementation may have beneficial 
role in antiviral defense in preschool asthmatic children when used 
with recommended doses. However, an intervention study is war-
ranted. Our findings also highlight the significance of RV infection as 
a meaningful clinical marker for short- and medium-term outcomes 
in preschool asthma. This information adds to the potential of direct 
RV detection, as well as RV antibody detection,34 to be used as an 
approach for personalized medication.35
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